August 31, 2023
The first over-the-counter opioid overdose reversal medication is heading to stores this week.
On Wednesday, Emergent BioSolutions announced its product, Narcan, would be available in the coming days. Narcan is the nasal version of Naloxone, which is the standard treatment for opioid overdoses.
Narcan was approved by the FDA for over-the-counter use during March. The announcement comes as the nation continues to grapple with a national public health overdose crisis.
“The FDA remains committed to addressing the evolving complexities of the overdose crisis,” FDA Commissioner Robert M. Califf, MD, said in a statement following the approval of the drug. “As part of this work, the agency has used its regulatory authority to facilitate greater access to naloxone by encouraging the development of and approving an over-the-counter naloxone product to address the dire public health need.”
Here’s what you need to know:
HAP and Pennsylvania’s hospitals are committed to providing care for patients with substance use disorder and other behavioral health needs. Learn more about our behavioral health advocacy.
Additional information about Naloxone in Pennsylvania is available online.
Tags: Substance Use Disorder | Behavioral Health
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.